The Minnesota Timberwolves have played a basketball game since March due to the COVID-19 pandemic.
Despite the lack of action in hardwood, the team is helping to pave the way off the field. The Timberwolves, led by vice president of basketball performance and technology Robthrough Sikka, were instrumental in NBA and NBPA studios to expand COVID-19 control recently.FDA-approved salivaDirect.
The check is one of the most profitable tactics for tripping over the virus and has produced a very small margin of error in recent months.Sikka and The Wolves doctors began reviewing players and their families on their return to the Twin Cities.for individual training.
“For us, we check the family, check the players, check the staff and review them six days a week,” Sikka told CNN.”And for us, being able to do that has given our organization a margin of protection.with what you feel most comfortable with. But, you know, when the value is as low as it is and it’s as undeniable as that, it’s anything that works out of the NBA box.”
For more information on nba and NBPA investment for the SalivaDirect test, see Zach Lowe’s profile at ESPN.com.